Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1989 1
1991 1
1996 1
1999 2
2002 1
2003 1
2004 1
2005 3
2006 2
2007 5
2008 8
2009 5
2010 7
2011 16
2012 26
2013 22
2014 39
2015 31
2016 35
2017 38
2018 46
2019 68
2020 75
2021 69
2022 65
2023 8
Text availability
Article attribute
Article type
Publication date

Search Results

491 results
Results by year
Filters applied: Randomized Controlled Trial. Clear all
Page 1
Did you mean turmeric (230 results)?
Curcumin and inflammation in non-alcoholic fatty liver disease: a randomized, placebo controlled clinical trial.
Saadati S, Sadeghi A, Mansour A, Yari Z, Poustchi H, Hedayati M, Hatami B, Hekmatdoost A. Saadati S, et al. BMC Gastroenterol. 2019 Jul 25;19(1):133. doi: 10.1186/s12876-019-1055-4. BMC Gastroenterol. 2019. PMID: 31345163 Free PMC article. Clinical Trial.
BACKGROUND: The aim of the present study was to evaluate the effects of curcumin supplementation on inflammatory indices, and hepatic features in patients with non-alcoholic fatty liver disease (NAFLD). METHODS: Fifty patients with NAFLD were randomized to receive lifestyl …
BACKGROUND: The aim of the present study was to evaluate the effects of curcumin supplementation on inflammatory indices, and hepatic …
Herbal formulation "turmeric extract, black pepper, and ginger" versus Naproxen for chronic knee osteoarthritis: A randomized, double-blind, controlled clinical trial.
Heidari-Beni M, Moravejolahkami AR, Gorgian P, Askari G, Tarrahi MJ, Bahreini-Esfahani N. Heidari-Beni M, et al. Phytother Res. 2020 Aug;34(8):2067-2073. doi: 10.1002/ptr.6671. Epub 2020 Mar 16. Phytother Res. 2020. PMID: 32180294 Clinical Trial.
Osteoarthritis is the most common articular disease that can lead to chronic pain and severe disability. Curcumin-an effective ingredient in turmeric with anti inflammatory property-plays an important role in protecting the joints against destructive factors. Gingerols and …
Osteoarthritis is the most common articular disease that can lead to chronic pain and severe disability. Curcumin-an effective ingred …
Curcumin extract for prevention of type 2 diabetes.
Chuengsamarn S, Rattanamongkolgul S, Luechapudiporn R, Phisalaphong C, Jirawatnotai S. Chuengsamarn S, et al. Diabetes Care. 2012 Nov;35(11):2121-7. doi: 10.2337/dc12-0116. Epub 2012 Jul 6. Diabetes Care. 2012. PMID: 22773702 Free PMC article. Clinical Trial.
OBJECTIVE: To assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetic population. ...Therefore, this study demonstrated that the curcumin intervention in a prediabetic population may be beneficial....
OBJECTIVE: To assess the efficacy of curcumin in delaying development of type 2 diabetes mellitus (T2DM) in the prediabetic populatio …
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients.
Valizadeh H, Abdolmohammadi-Vahid S, Danshina S, Ziya Gencer M, Ammari A, Sadeghi A, Roshangar L, Aslani S, Esmaeilzadeh A, Ghaebi M, Valizadeh S, Ahmadi M. Valizadeh H, et al. Int Immunopharmacol. 2020 Dec;89(Pt B):107088. doi: 10.1016/j.intimp.2020.107088. Epub 2020 Oct 20. Int Immunopharmacol. 2020. PMID: 33129099 Free PMC article. Clinical Trial.
However, there is no decisive treatment approach available for this disorder, which is primarily attributed to the large amount of inflammatory cytokine production. We aimed to identify the effects of Nano-curcumin on the modulation of inflammatory cytokines in COVID-19 pa …
However, there is no decisive treatment approach available for this disorder, which is primarily attributed to the large amount of inflammat …
Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial.
Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, Sahebkar A. Rahmani S, et al. Phytother Res. 2016 Sep;30(9):1540-8. doi: 10.1002/ptr.5659. Epub 2016 Jun 8. Phytother Res. 2016. PMID: 27270872 Clinical Trial.
In this randomized double-blind placebo-controlled trial, patients with ultrasonographic evidence of NAFLD were randomly assigned to receive an amorphous dispersion curcumin formulation (500 mg/day equivalent to 70-mg curcumin) or matched placebo for a period of 8 w …
In this randomized double-blind placebo-controlled trial, patients with ultrasonographic evidence of NAFLD were randomly assigned to receive …
Effect of Curcumin Supplementation on Exercise-Induced Oxidative Stress, Inflammation, Muscle Damage, and Muscle Soreness.
Ms SAB, Waldman PhD HS, Krings PhD BM, Lamberth PhD J, Smith PhD JW, McAllister PhD MJ. Ms SAB, et al. J Diet Suppl. 2020;17(4):401-414. doi: 10.1080/19390211.2019.1604604. Epub 2019 Apr 26. J Diet Suppl. 2020. PMID: 31025894 Clinical Trial.
Curcumin has been shown to reduce exercise-induced oxidative stress (OS) and inflammation. ...Future research should investigate chronic curcumin supplementation and its mechanistic effects on muscle recovery from exercise....
Curcumin has been shown to reduce exercise-induced oxidative stress (OS) and inflammation. ...Future research should investigate chro
Safety and efficacy of curcumin versus diclofenac in knee osteoarthritis: a randomized open-label parallel-arm study.
Shep D, Khanwelkar C, Gade P, Karad S. Shep D, et al. Trials. 2019 Apr 11;20(1):214. doi: 10.1186/s13063-019-3327-2. Trials. 2019. PMID: 30975196 Free PMC article. Clinical Trial.
At day 28, a weight-lowering effect (P <0.01) and anti-ulcer effect (P <0.01) of curcumin were observed. None of the patients required H2 blockers in the curcumin group, and 19 patients required H2 blockers in the diclofenac group (0% versus 28%, respectively; …
At day 28, a weight-lowering effect (P <0.01) and anti-ulcer effect (P <0.01) of curcumin were observed. None of the patients r …
Effectiveness of Curcuma longa Extract for the Treatment of Symptoms and Effusion-Synovitis of Knee Osteoarthritis : A Randomized Trial.
Wang Z, Jones G, Winzenberg T, Cai G, Laslett LL, Aitken D, Hopper I, Singh A, Jones R, Fripp J, Ding C, Antony B. Wang Z, et al. Ann Intern Med. 2020 Dec 1;173(11):861-869. doi: 10.7326/M20-0990. Epub 2020 Sep 15. Ann Intern Med. 2020. PMID: 32926799 Clinical Trial.
BACKGROUND: Current pharmacologic therapies for patients with osteoarthritis are suboptimal. OBJECTIVE: To determine the efficacy of Curcuma longa extract (CL) for reducing knee symptoms and effusion-synovitis in patients with symptomatic knee osteoarthritis and knee effus …
BACKGROUND: Current pharmacologic therapies for patients with osteoarthritis are suboptimal. OBJECTIVE: To determine the efficacy of Curc
491 results